Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2006 1
2007 4
2008 6
2009 7
2010 11
2011 23
2012 28
2013 23
2014 27
2015 19
2016 30
2017 18
2018 12
2019 11
2020 11
2021 10
2022 13
2023 16
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

227 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials.
Wykoff CC, Abreu F, Adamis AP, Basu K, Eichenbaum DA, Haskova Z, Lin H, Loewenstein A, Mohan S, Pearce IA, Sakamoto T, Schlottmann PG, Silverman D, Sun JK, Wells JA, Willis JR, Tadayoni R; YOSEMITE and RHINE Investigators. Wykoff CC, et al. Lancet. 2022 Feb 19;399(10326):741-755. doi: 10.1016/S0140-6736(22)00018-6. Epub 2022 Jan 24. Lancet. 2022. PMID: 35085503 Clinical Trial.
Pharmacovitrectomy.
Dolz-Marco R, Gallego-Pinazo R, Díaz-Llopis M, Arévalo JF. Dolz-Marco R, et al. Among authors: gallego pinazo r. Dev Ophthalmol. 2014;54:126-34. doi: 10.1159/000360458. Epub 2014 Aug 26. Dev Ophthalmol. 2014. PMID: 25196761 Review.
Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial.
Khanani AM, Patel SS, Staurenghi G, Tadayoni R, Danzig CJ, Eichenbaum DA, Hsu J, Wykoff CC, Heier JS, Lally DR, Monés J, Nielsen JS, Sheth VS, Kaiser PK, Clark J, Zhu L, Patel H, Tang J, Desai D, Jaffe GJ; GATHER2 trial investigators. Khanani AM, et al. Lancet. 2023 Oct 21;402(10411):1449-1458. doi: 10.1016/S0140-6736(23)01583-0. Epub 2023 Sep 8. Lancet. 2023. PMID: 37696275
Retinal pigment epithelial tears.
Sastre-Ibáñez M, Martínez-Rubio C, Molina-Pallete R, Martínez-López-Corell P, Wu L, Arévalo JF, Gallego-Pinazo R. Sastre-Ibáñez M, et al. Among authors: gallego pinazo r. J Fr Ophtalmol. 2019 Jan;42(1):63-72. doi: 10.1016/j.jfo.2018.04.017. Epub 2018 Dec 26. J Fr Ophtalmol. 2019. PMID: 30594420 Review.
Susac's syndrome: an update.
Sauma J, Rivera D, Wu A, Donate-Lopez J, Gallego-Pinazo R, Chilov M, Wu M, Wu L. Sauma J, et al. Among authors: gallego pinazo r. Br J Ophthalmol. 2020 Sep;104(9):1190-1195. doi: 10.1136/bjophthalmol-2019-315597. Epub 2020 Feb 6. Br J Ophthalmol. 2020. PMID: 32029433 Review.
Optic nerve melanocytoma.
Gallego-Pinazo R, Dolz-Marco R, Vila-Arteaga J, Marí Cotino JF, España-Gregori E. Gallego-Pinazo R, et al. Arch Soc Esp Oftalmol. 2016 Sep;91(9):e83. doi: 10.1016/j.oftal.2016.05.014. Epub 2016 Jul 1. Arch Soc Esp Oftalmol. 2016. PMID: 27378454 English, Spanish. No abstract available.
Efficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in Japanese patients with diabetic macular edema: 1-year results from the Japan subgroup of the phase 3 YOSEMITE trial.
Shimura M, Kitano S, Ogata N, Mitamura Y, Oh H, Ochi H, Ohsawa S, Hirakata A; YOSEMITE and RHINE Investigators. Shimura M, et al. Jpn J Ophthalmol. 2023 May;67(3):264-279. doi: 10.1007/s10384-023-00979-8. Epub 2023 Mar 10. Jpn J Ophthalmol. 2023. PMID: 36897413 Free PMC article. Clinical Trial.
Retinal neurodegeneration in age-related macular degeneration.
Barresi C, Chhablani J, Dolz-Marco R, Gallego-Pinazo R, Berni A, Bandello F, Borrelli E. Barresi C, et al. Among authors: gallego pinazo r. Eur J Ophthalmol. 2024 May;34(3):624-630. doi: 10.1177/11206721231186166. Epub 2023 Jul 2. Eur J Ophthalmol. 2024. PMID: 37394731 Review.
Current limitations and future of optical coherence tomography angiography.
Protsyk O, Gallego-Pinazo R, Dolz-Marco R. Protsyk O, et al. Among authors: gallego pinazo r. Arch Soc Esp Oftalmol (Engl Ed). 2022 Aug;97(8):421-423. doi: 10.1016/j.oftale.2022.03.012. Epub 2022 May 24. Arch Soc Esp Oftalmol (Engl Ed). 2022. PMID: 35624061 No abstract available.
Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials.
Wong TY, Haskova Z, Asik K, Baumal CR, Csaky KG, Eter N, Ives JA, Jaffe GJ, Korobelnik JF, Lin H, Murata T, Ruamviboonsuk P, Schlottmann PG, Seres AI, Silverman D, Sun X, Tang Y, Wells JA, Yoon YH, Wykoff CC; YOSEMITE and RHINE Investigators. Wong TY, et al. Ophthalmology. 2023 Dec 28:S0161-6420(23)00933-8. doi: 10.1016/j.ophtha.2023.12.026. Online ahead of print. Ophthalmology. 2023. PMID: 38158159 Free article.
227 results